28.90
-0.60
(-2.03%)
At close: 1:30:24 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-515,681.00
-596,887.00
-171,874.00
-112,567.00
-127,117.00
Investing Cash Flow
-462,710.00
-751,432.00
22,632.00
118,555.00
-140,228.00
Financing Cash Flow
-498.00
1,458,326.00
587,485.00
310,731.00
-2,489.00
End Cash Position
735,950.00
947,997.00
837,990.00
399,747.00
83,028.00
Capital Expenditure
-3,199.00
-3,704.00
-1,211.00
-514.00
-366.00
Issuance of Capital Stock
--
1,411,130.00
576,214.00
295,629.00
--
Free Cash Flow
-518,880.00
-600,591.00
-173,085.00
-113,081.00
-127,483.00
12/31/2020 - 12/9/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%
6657.TW Energenesis Biomedical CO.,LTD.
50.90
+1.39%
6550.TW Polaris Group
43.40
+0.46%
3164.TW GenMont Biotech Incorporation
19.45
+1.04%
6919.TW CALIWAY BIOPHARMACEUTICALS CO L
665.00
+3.74%
1733.TW Apex Biotechnology Corp.
29.95
0.00%
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
33.20
+0.30%
6580.TWO TaiRx, Inc.
26.00
+1.96%
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%